ARCHIVES

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

This article is from The Cancer Letter archive.

Vol. 11 No. 14 | April 5, 1985

Download PDF Visit The Full Archive

Related Articles

In Brief: Pasche Named Director of Wake Forest Cancer Center

March 7, 2014

Study: HPV Testing Can Predict Precancers For Nearly Two Decades Following Exam

August 31, 2012

1981 Budget By Funding Mechanism

June 1, 1979

Adjuvant Chemo Improves Survival In Early Lung Cancer

July 30, 2004

“We Need You.” Everyone Tells ACCC

February 6, 1976

In Brief: No Intention Of Cutting Back On Cancer, Heart Research, Weinberger Spokesman Insists

June 7, 1974